Zoetis | ZTS - Sales Revenues

Stock Price
116.80
Daily Change
-1.46 -1.23%
Monthly
-4.54%
Yearly
-19.12%
Q2 Forecast
114.39

Zoetis reported $2.4B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
AbbVie USD 16.62B 840M Dec/2025
Align Technology USD 1.05B 54.3M Dec/2025
Bayer EUR 11.44B 1.78B Dec/2025
Bristol-Myers Squibb USD 12.5B 300M Dec/2025
Charles River Laboratories USD 994.2M 5.8M Dec/2025
Coherus Biosciences USD 12.75M 1.18M Dec/2025
Dentsply International USD 961M 57M Dec/2025
Eli Lilly USD 19.3B 1.7B Dec/2025
Henry Schein USD 3.4B 60M Dec/2025
Idexx Laboratories USD 1.09B 10M Dec/2025
Illumina USD 1.16B 80M Dec/2025
IQVIA Holdings USD 4.36B 260M Dec/2025
J&J USD 24.6B 610M Dec/2025
Laboratory Of America USD 3.52B 40M Dec/2025
Merck USD 16.4B 880M Dec/2025
Neogen USD 224.69M 15.5M Sep/2025
Pacira USD 196.87M 17.35M Dec/2025
Perrigo USD 1.11B 70M Dec/2025
Pfizer USD 17.58B 880M Dec/2025
Phibro Animal Health USD 373.91M 10.02M Dec/2025
Quest Diagnostics USD 2.81B 10M Dec/2025
Sanofi EUR 11.3B 1.13B Dec/2025
Sanofi EUR 12.2B 3.19B Dec/2025
Zoetis USD 2.4B 0 Dec/2025